Efficacy and Safety of Sirolimus for Treating COVID-19 Infection
Latest Information Update: 05 Sep 2022
At a glance
- Drugs Sirolimus (Primary)
- Indications COVID 2019 infections; Pneumonia
- Focus Therapeutic Use
- 06 Sep 2020 Planned End Date changed from 30 Oct 2020 to 30 Nov 2020.
- 06 Sep 2020 Planned primary completion date changed from 30 Sep 2020 to 30 Oct 2020.
- 06 Sep 2020 Status changed from not yet recruiting to recruiting.